---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-188088"
form_type: "8-K"
ticker: "OLPX"
cik: "0001868726"
company_name: "OLAPLEX HOLDINGS, INC."
filed_at: "2025-08-26T23:59:59+00:00"
generated_at: "2026-05-17T10:01:05.976320+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Olaplex acquires biotech firm Purvala Bioscience for $10.5M in cash

## Summary
- Purchase price $10.5M, subject to adjustments; $1.05M escrowed for 15 months for indemnification.
- Purvala is a Boston biotech founded by MIT professor Dr. Bradley Olsen, focused on bioinspired molecules for health/beauty.
- This is Olaplex's first acquisition since its launch over 10 years ago, signaling renewed innovation push.
- Olaplex CEO Amanda Baldwin said Purvala tech could create 'next generation of disruptive science-backed product innovation'.

## SEC filing metadata
- accession: 0001193125-25-188088
- form_type: 8-K
- ticker: OLPX
- cik: 0001868726
- company_name: OLAPLEX HOLDINGS, INC.
- filed_at: 2025-08-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1868726/000119312525188088/0001193125-25-188088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1868726/000119312525188088/d70869d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-188088
- JSON: https://secwatch.observer/filing/0001193125-25-188088.json
- Plain text: https://secwatch.observer/filing/0001193125-25-188088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.